These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9257335)

  • 1. In vivo binding of [18F]altanserin to rat brain 5HT2 receptors: a film and electronic autoradiographic study.
    Biver F; Lotstra F; Monclus M; Dethy S; Damhaut P; Wikler D; Luxen A; Goldman S
    Nucl Med Biol; 1997 May; 24(4):357-60. PubMed ID: 9257335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
    Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
    Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin 5HT2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [18F]altanserin: results in young normal controls.
    Sadzot B; Lemaire C; Maquet P; Salmon E; Plenevaux A; Degueldre C; Hermanne JP; Guillaume M; Cantineau R; Comar D
    J Cereb Blood Flow Metab; 1995 Sep; 15(5):787-97. PubMed ID: 7673371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent.
    Tan PZ; Baldwin RM; Van Dyck CH; Al-Tikriti M; Roth B; Khan N; Charney DS; Innis RB
    Nucl Med Biol; 1999 Aug; 26(6):601-8. PubMed ID: 10587097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicompartmental study of fluorine-18 altanserin binding to brain 5HT2 receptors in humans using positron emission tomography.
    Biver F; Goldman S; Luxen A; Monclus M; Forestini M; Mendlewicz J; Lotstra F
    Eur J Nucl Med; 1994 Sep; 21(9):937-46. PubMed ID: 7995287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET quantification of 5-HT2A receptors in the human brain: a constant infusion paradigm with [18F]altanserin.
    van Dyck CH; Tan PZ; Baldwin RM; Amici LA; Garg PK; Ng CK; Soufer R; Charney DS; Innis RB
    J Nucl Med; 2000 Feb; 41(2):234-41. PubMed ID: 10688105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of synaptic serotonin level on [18F]altanserin binding to 5HT2 receptors in man.
    Larisch R; Klimke A; Hamacher K; Henning U; Estalji S; Hohlfeld T; Vosberg H; Tosch M; Gaebel W; Coenen HH; Müller-Gärtner HW
    Behav Brain Res; 2003 Feb; 139(1-2):21-9. PubMed ID: 12642173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.
    Rosier A; Dupont P; Peuskens J; Bormans G; Vandenberghe R; Maes M; de Groot T; Schiepers C; Verbruggen A; Mortelmans L
    Psychiatry Res; 1996 Nov; 68(1):11-22. PubMed ID: 9027929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, affinity and specificity of 18F-setoperone, a potential ligand for in-vivo imaging of cortical serotonin receptors.
    Maziere B; Crouzel C; Venet M; Stulzaft O; Sanz G; Ottaviani M; Sejourne C; Pascal O; Bisserbe JC
    Int J Rad Appl Instrum B; 1988; 15(4):463-8. PubMed ID: 3255742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorine-18-altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats.
    Lemaire C; Cantineau R; Guillaume M; Plenevaux A; Christiaens L
    J Nucl Med; 1991 Dec; 32(12):2266-72. PubMed ID: 1744713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET.
    Hansen HD; Ettrup A; Herth MM; Dyssegaard A; Ratner C; Gillings N; Knudsen GM
    Synapse; 2013 Jun; 67(6):328-37. PubMed ID: 23390031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of 5-HT2A receptors in the human brain using [18F]altanserin-PET and the bolus/infusion approach.
    Pinborg LH; Adams KH; Svarer C; Holm S; Hasselbalch SG; Haugbøl S; Madsen J; Knudsen GM
    J Cereb Blood Flow Metab; 2003 Aug; 23(8):985-96. PubMed ID: 12902843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disturbance of serotonin 5HT2 receptors in remitted patients suffering from hereditary depressive disorder.
    Larisch R; Klimke A; Mayoral F; Hamacher K; Herzog HR; Vosberg H; Tosch M; Gaebel W; Rivas F; Coenen HH; Müller-Gärtner HW
    Nuklearmedizin; 2001 Aug; 40(4):129-34. PubMed ID: 11556203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.
    Kristiansen H; Elfving B; Plenge P; Pinborg LH; Gillings N; Knudsen GM
    Synapse; 2005 Dec; 58(4):249-57. PubMed ID: 16206185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoradiographic studies of 5HT2 receptors.
    Saavedra JM; Himeno A
    Adv Exp Med Biol; 1991; 294():107-13. PubMed ID: 1772060
    [No Abstract]   [Full Text] [Related]  

  • 16. [¹⁸F]Altanserin and small animal PET: impact of multidrug efflux transporters on ligand brain uptake and subsequent quantification of 5-HT₂A receptor densities in the rat brain.
    Kroll T; Elmenhorst D; Matusch A; Celik AA; Wedekind F; Weisshaupt A; Beer S; Bauer A
    Nucl Med Biol; 2014 Jan; 41(1):1-9. PubMed ID: 24120220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equilibrium modeling of 5-HT(2A) receptors with [18F]deuteroaltanserin and PET: feasibility of a constant infusion paradigm.
    van Dyck CH; Soares JC; Tan PZ; Staley JK; Baldwin RM; Amici LA; Fu X; Garg PK; Seibyl JP; Charney DS; Innis RB
    Nucl Med Biol; 2000 Nov; 27(8):715-22. PubMed ID: 11150702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central serotonergic S2 binding in Papio anubis measured in vivo with N-omega-[18F]fluoroethylketanserin and PET.
    Moerlein SM; Perlmutter JS
    Neurosci Lett; 1991 Feb; 123(1):23-6. PubMed ID: 2062450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
    Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
    J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin.
    Ettrup A; Svarer C; McMahon B; da Cunha-Bang S; Lehel S; Møller K; Dyssegaard A; Ganz M; Beliveau V; Jørgensen LM; Gillings N; Knudsen GM
    Neuroimage; 2016 Apr; 130():167-174. PubMed ID: 26876490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.